ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer

June 24, 2005

Coffin, McIntosh Named Cancer Society Research Professors

February 11, 1994

Cancer Control RFA Announcements

March 9, 1979

DePinho’s Wife Was Briefed on AVEO Data 11 Days Before He Touted Stock on CNBC

September 13, 2013

Rosenberg Starts New Study With TIL; LAK-IL-2 Costs Clarified

November 28, 1986

$3.3 Million For Retinoid Contract Awarded

October 14, 1977